The third IQN Path In-situ Methods working group meeting
On Friday 1st September, prior to the European Congress of Pathology meeting, IQN Path held its 3rd In-situ Methods working group face to face meeting. Prof Mogens Vyberg (NordiQC) and John Garratt (CIQC) chaired the session. The agenda opened with a short summary on the progress of IQN Path’s activities and discussions of the Working Group read more…
IQN Path’s Exhibition booth, ECP 2017 Amsterdam
This year IQN Path ASBL had it’s first exhibition booth at the 29th European Congress of Pathology, 2-5th September, 2017 https://www.esp-congress.org. As well as meeting with many IQN Path members, we also had the opportunity to speak with new potential members and also with laboratories looking to join EQA schemes. Many different projects and next read more…
New Publication: Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers’ survey
IQN Path is pleased to announce the first publication on Liquid Biopsy clinical implementation and quality assessment. Four EQA providers came together under the umbrella of IQN Path ASBL to run a pilot External Quality Assessment scheme for circulating free DNA. This publication “Review of the implementation of plasma ctDNA testing on behalf of IQN Path read more…
Quality in Pathology – IQN Path ASBL initiates a journal special issue
During the IQN Path Annual General Meeting in 2017, an idea was born to identify a channel for publications relating to quality issues in pathology, that would also provide a vehicle to collate papers and interesting articles related to External Quality Assessment in Pathology, amongst other topics that touch on quality. IQN Path ASBL reached read more…
IQN Path cfDNA workshop: Florence 23rd June 2017
On the 23rd of June IQN Path organised the first IQN Path workshop on circulating free DNA testing. This meeting was held in the beautiful city of Florence, Italy. The meeting had over 100 registrants and drew attendees from 23 different countries in total demonstrating the importance and interest in the topic of quality for read more…
6th Meeting on External Quality Assessment in Molecular Pathology – Naples 2017
For the sixth consecutive year, representatives of the stakeholders involved in promoting accurate diagnostic testing in pathology for effective anti-cancer drug selection gathered in the second weekend of May 2017, in Naples, Italy. This very dynamic meeting always brings much discussion of the current key issues, and importantly, proposed solutions to optimising diagnostic testing quality read more…
Quality Assurance for Clinical Immunohistochemistry
IQN Path and the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) have put together a 4-part series on Quality Assurance for Clinical Immunohistochemistry. “Evolution of Quality Assurance for Clinical Immunohistochemistry (IHC) in the Era of Precision Medicine” from the lead author Emina Torlakovic. – Part 1: Fit-for-purpose Approach to Classification of Clinical IHC Biomarkers – read more…
New Article in ESMO Open
In April this year, for the fifth consecutive year, representatives of all stakeholders involved in promoting accurate diagnostic testing for anticancer drug selection gathered in Naples in order to optimise the chance that patients will have an appropriate test which forms the basis for the decision of administering targeted treatment. The article published on ESMO read more…
XXXI International Congress of the IAP and 28th Congress of the ESP in Cologne
IQN Path took part in the XXXI International Congress of the IAP and 28th Congress of the ESP in Cologne (September 25-29). IQN Path had several presentations in the EQA Session of the Two Day Symposium for Molecular Biologists involved in Molecular Pathology Diagnostics and Research. Dr Sandi Deans presented on behalf of IQN Path read more…